Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Systemic lupus erythematosus: an update

- Featured Image

Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease. Predominantly affecting young women, it continues to have an unacceptably high morbidity burden.1 Its clinical heterogeneity often makes diagnosis and management challenging even for experienced physicians. Additionally, the natural history of SLE is variable, with some patients experiencing fluctuating periods of relative inactivity contrasted by disease flare while others have persistently active disease.2 The classification criteria for SLE have recently been reappraised, and the new criteria have facilitated a more robust diagnostic process. The treatment approach of early and sustained control of disease activity is likely to lead to the prevention of irreversible end-organ damage,3 which correlates with early mortality.4 Advances have also been made in the therapeutic area, based on the exciting translational research identifying new targets that develop into therapies promising to ameliorate disease activity and lessen the reliance on treatments such as glucocorticoids. Patients with SLE experience poor health-related quality of life (HR-QoL),5 which can be worse than in groups with other chronic diseases such as congestive cardiac failure, myocardial infarction and diabetes.6 The determinants…

email